Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
FDA outlines draft policy on MRD for accelerated approval
The guidance provides recommendations for designing clinical trials that use MRD or CR as endpoints for accelerated approval in multiple myeloma.
Angus Liu
Jan 21, 2026 2:55pm
Fierce Pharma
Pfizer CEO blasts RFK Jr. over 'anti-science' vaccine stance: WSJ
Jan 21, 2026 11:01am
Inside Beam's 'big push' for in vivo gene editing
Jan 21, 2026 7:52am
Takeda leader says AI gave early-stage asset a 'phoenix' rebirth
Jan 13, 2026 6:16am
BrainSpace gets FDA clearance for brain fluid management system
Jan 6, 2026 4:05pm
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Jan 6, 2026 4:30am
